603939 益丰药房
已收盘 03-27 15:00:00
资讯
新帖
简况
益丰药房（603939）披露聘任李松峰为副总裁公告，3月27日股价上涨0.79%
证券之星 · 03-27 17:25
益丰药房（603939）披露聘任李松峰为副总裁公告，3月27日股价上涨0.79%
益丰药房（603939）披露高级管理人员减持计划实施结果公告，3月6日股价上涨2.28%
中金财经 · 03-07
益丰药房（603939）披露高级管理人员减持计划实施结果公告，3月6日股价上涨2.28%
益丰药房：3月6日高管肖再祥减持股份合计6万股
证券之星 · 03-06
益丰药房：3月6日高管肖再祥减持股份合计6万股
每周股票复盘：益丰药房（603939）益丰转债将于3月4日付息
证券之星 · 03-01
每周股票复盘：益丰药房（603939）益丰转债将于3月4日付息
益丰药房（603939）披露可转换公司债券付息公告，2月24日股价下跌0.45%
证券之星 · 02-24
益丰药房（603939）披露可转换公司债券付息公告，2月24日股价下跌0.45%
每周股票复盘：益丰药房（603939）不修正转债价格
证券之星 · 02-08
每周股票复盘：益丰药房（603939）不修正转债价格
益丰药房（603939）披露关于不向下修正“益丰转债”转股价格的公告，2月5日股价上涨2.46%
证券之星 · 02-05
益丰药房（603939）披露关于不向下修正“益丰转债”转股价格的公告，2月5日股价上涨2.46%
益丰药房（603939）披露使用闲置募集资金进行现金管理的公告，2月3日股价上涨2.7%
证券之星 · 02-03
益丰药房（603939）披露使用闲置募集资金进行现金管理的公告，2月3日股价上涨2.7%
益丰药房（603939）披露预计触发“益丰转债”转股价格向下修正条件的提示性公告，2月2日股价下跌3.85%
证券之星 · 02-02
益丰药房（603939）披露预计触发“益丰转债”转股价格向下修正条件的提示性公告，2月2日股价下跌3.85%
益丰药房涨10.02%，中邮证券二个月前给出“买入”评级
证券之星 · 01-23
益丰药房涨10.02%，中邮证券二个月前给出“买入”评级
异动快报：益丰药房（603939）1月23日9点31分触及涨停板
证券之星 · 01-23
异动快报：益丰药房（603939）1月23日9点31分触及涨停板
每周股票复盘：益丰药房（603939）可转债转股5,571股
证券之星 · 01-11
每周股票复盘：益丰药房（603939）可转债转股5,571股
益丰药房（603939）披露为控股子公司提供担保的进展公告，1月7日股价上涨0.27%
证券之星 · 01-07
益丰药房（603939）披露为控股子公司提供担保的进展公告，1月7日股价上涨0.27%
益丰药房（603939）披露可转债转股结果暨股份变动公告，1月5日股价上涨0.69%
证券之星 · 01-05
益丰药房（603939）披露可转债转股结果暨股份变动公告，1月5日股价上涨0.69%
益丰药房（603939）披露为控股子公司提供担保的进展公告，12月4日股价下跌0.89%
证券之星 · 2025-12-04
益丰药房（603939）披露为控股子公司提供担保的进展公告，12月4日股价下跌0.89%
益丰药房（603939）披露2022年限制性股票激励计划部分限制性股票回购注销实施公告，11月24日股价下跌1.71%
证券之星 · 2025-11-24
益丰药房（603939）披露2022年限制性股票激励计划部分限制性股票回购注销实施公告，11月24日股价下跌1.71%
每周股票复盘：益丰药房（603939）高管拟合计减持不超21.39万股
证券之星 · 2025-11-23
每周股票复盘：益丰药房（603939）高管拟合计减持不超21.39万股
益丰药房最新公告：高管王永辉、肖再祥合计拟减持不超0.0176%股份
证券之星 · 2025-11-16
益丰药房最新公告：高管王永辉、肖再祥合计拟减持不超0.0176%股份
益丰药房（603939）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 2025-10-31
益丰药房（603939）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
图解益丰药房三季报：第三季度单季净利润同比增长10.14%
证券之星 · 2025-10-29
图解益丰药房三季报：第三季度单季净利润同比增长10.14%
加载更多
公司概况
公司名称：
益丰大药房连锁股份有限公司
所属行业：
零售业
上市日期：
2015-02-17
主营业务：
益丰大药房连锁股份有限公司的主营业务是中西成药、中药饮片、医疗器械、保健食品、保健用品、个人护理用品以及与健康相关联的日化便利、家居清洁等商品的全渠道零售业务。公司的主要产品是中西成药、中药、非药品。
发行价格：
19.47
{"stockData":{"symbol":"603939","market":"SH","secType":"STK","nameCN":"益丰药房","latestPrice":24.1,"timestamp":1774594800000,"preClose":23.91,"halted":0,"volume":5451542,"delay":0,"changeRate":0.0079,"floatShares":1212000000,"shares":1212000000,"eps":1.3549,"marketStatus":"已收盘","change":0.19,"latestTime":"03-27 15:00:00","open":23.85,"high":24.55,"low":23.83,"amount":132000000,"amplitude":0.0301,"askPrice":24.1,"askSize":23,"bidPrice":24.09,"bidSize":23,"shortable":0,"etf":0,"ttmEps":1.3549,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":5,"adr":0,"adjPreClose":23.91,"symbolType":"stock","openAndCloseTimeList":[[1774575000000,1774582200000],[1774587600000,1774594800000]],"highLimit":26.3,"lowLimit":21.52,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1212391959,"isCdr":false,"pbRate":2.67,"roa":"--","peRate":17.787291,"roe":"11.05%","epsLYR":1.26,"committee":0.270408,"marketValue":29219000000,"turnoverRate":0.0045,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-03-30。","floatMarketCap":29219000000},"requestUrl":"/m/hq/s/603939","defaultTab":"news","newsList":[{"id":"2622594842","title":"益丰药房（603939）披露聘任李松峰为副总裁公告，3月27日股价上涨0.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622594842","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622594842?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:25","pubTimestamp":1774603543,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，益丰药房报收于24.1元，较前一交易日上涨0.79%，最新总市值为292.19亿元。该股当日开盘23.85元，最高24.55元，最低23.83元，成交额达1.32亿元，换手率为0.45%。近日，益丰大药房连锁股份有限公司披露《第五届董事会第二十六次会议决议公告》。公告显示，公司于2026年3月27日召开第五届董事会第二十六次会议，审议通过《关于聘任高级管理人员的议案》，同意聘任李松峰先生为公司副总裁，任期至第五届董事会任期届满。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700036450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","LU2148510915.USD","LU1064131003.USD","LU2460026573.USD","603939","LU1064130708.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2617656030","title":"益丰药房（603939）披露高级管理人员减持计划实施结果公告，3月6日股价上涨2.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617656030","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617656030?lang=zh_cn&edition=full","pubTime":"2026-03-07 08:35","pubTimestamp":1772843734,"startTime":"0","endTime":"0","summary":"近日，益丰大药房连锁股份有限公司发布《关于高级管理人员减持计划实施期限届满暨实施结果公告》。公告显示，公司副总裁王永辉、肖再祥于2025年11月17日披露减持计划，减持期间为2025年12月8日至2026年3月7日。本次减持计划已实施完毕，实际减持情况与此前披露一致，未提前终止，无违规情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260307/32051467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1064131003.USD","LU2460026573.USD","LU1064130708.USD","BK0209","LU2488822045.USD","603939","LU2148510915.USD"],"gpt_icon":0},{"id":"2617685753","title":"益丰药房：3月6日高管肖再祥减持股份合计6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2617685753","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617685753?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:13","pubTimestamp":1772788432,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月6日市场公开信息、上市公司公告及交易所披露数据整理，益丰药房最新董监高及相关人员股份变动情况：2026年3月6日公司副总裁肖再祥共减持公司股份6.0万股，占公司总股本为0.0049%。益丰药房近半年内的董监高及核心技术人员增减持详情如下：益丰药房的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入143.23万，融资余额增加；融券净流入3600.0，融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600027639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","LU1064130708.USD","603939","BK0209","LU2460026573.USD","LU2488822045.USD","LU2148510915.USD"],"gpt_icon":0},{"id":"2616843007","title":"每周股票复盘：益丰药房（603939）益丰转债将于3月4日付息","url":"https://stock-news.laohu8.com/highlight/detail?id=2616843007","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616843007?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:33","pubTimestamp":1772303590,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，益丰药房报收于24.3元，较上周的24.4元下跌0.41%。本周关注点公司公告汇总：益丰转债将于2026年3月4日支付第二年利息，票面利率0.50%。本次付息对象为截至债权登记日在中国证券登记结算有限责任公司上海分公司登记在册的全体“益丰转债”持有人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","LU2460026573.USD","LU1064130708.USD","BK0209","LU2488822045.USD","603939","LU2148510915.USD"],"gpt_icon":0},{"id":"2613976957","title":"益丰药房（603939）披露可转换公司债券付息公告，2月24日股价下跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613976957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613976957?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:37","pubTimestamp":1771929434,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，益丰药房报收于24.29元，较前一交易日下跌0.45%，最新总市值为294.49亿元。该股当日开盘24.42元，最高24.52元，最低24.1元，成交额达1.18亿元，换手率为0.4%。近日，益丰药房发布《关于可转换公司债券付息的公告》。公告显示，公司于2024年3月4日发行可转换公司债券，将于2026年3月4日支付第二年利息，计息期间为2025年3月4日至2026年3月3日，票面利率为0.50%，每张兑息金额为0.50元（含税）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400037572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","LU2148510915.USD","LU1064130708.USD","LU1064131003.USD","LU2460026573.USD","LU2488822045.USD","603939"],"gpt_icon":0},{"id":"2609525518","title":"每周股票复盘：益丰药房（603939）不修正转债价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2609525518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609525518?lang=zh_cn&edition=full","pubTime":"2026-02-08 01:50","pubTimestamp":1770486622,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，益丰药房报收于25.19元，较上周的23.89元上涨5.44%。本周，益丰药房2月5日盘中最高价报25.8元。本周关注点公司公告汇总：益丰药房决定不向下修正“益丰转债”转股价格，并在未来3个月内如再次触发修正条款亦不修正。自2026年1月16日至2月5日，益丰药房股票收盘价在连续三十个交易日内有十五个交易日低于当期转股价格的85%，已触发“益丰转债”转股价格向下修正条款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU2488822045.USD","LU2148510915.USD","LU1064131003.USD","603939","BK0209","LU2460026573.USD"],"gpt_icon":0},{"id":"2609030980","title":"益丰药房（603939）披露关于不向下修正“益丰转债”转股价格的公告，2月5日股价上涨2.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609030980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609030980?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:10","pubTimestamp":1770300628,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，益丰药房报收于25.37元，较前一交易日上涨2.46%，最新总市值为307.58亿元。该股当日开盘24.96元，最高25.8元，最低24.76元，成交额达6.18亿元，换手率为2.01%。近日，益丰药房发布《关于不向下修正“益丰转债”转股价格的公告》。公告显示，自2026年1月16日至2月5日，公司股票收盘价在连续三十个交易日内有十五个交易日低于当期转股价格的85%，已触发“益丰转债”转股价格向下修正条款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","603939","LU2148510915.USD","LU1064130708.USD","LU2488822045.USD","LU2460026573.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2608872003","title":"益丰药房（603939）披露使用闲置募集资金进行现金管理的公告，2月3日股价上涨2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608872003","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608872003?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:23","pubTimestamp":1770128595,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，益丰药房报收于23.59元，较前一交易日上涨2.7%，最新总市值为286亿元。近日，益丰大药房连锁股份有限公司发布《关于使用闲置募集资金进行现金管理的公告》。公告显示，公司使用闲置募集资金11,200万元进行现金管理，购买结构性存款产品，投资期限分别为90天、27天和25天，受托方包括长沙银行、中信银行和招商银行。最近12个月内累计使用闲置募集资金进行现金管理最高单日余额为22,600万元，尚未收回本金金额为18,200万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300043173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","LU2488822045.USD","BK0209","LU1064130708.USD","603939","LU2148510915.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2608044862","title":"益丰药房（603939）披露预计触发“益丰转债”转股价格向下修正条件的提示性公告，2月2日股价下跌3.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608044862","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608044862?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:11","pubTimestamp":1770041488,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，益丰药房报收于22.97元，较前一交易日下跌3.85%，最新总市值为278.49亿元。该股当日开盘23.89元，最高23.89元，最低22.9元，成交额达4.72亿元，换手率为1.67%。近日，益丰大药房连锁股份有限公司发布关于预计触发“益丰转债”转股价格向下修正条件的提示性公告。公司将在触发当日召开董事会审议是否修正转股价格，并及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","LU1064130708.USD","603939","BK0209","LU2460026573.USD","LU2488822045.USD","LU2148510915.USD"],"gpt_icon":0},{"id":"2605424061","title":"益丰药房涨10.02%，中邮证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2605424061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605424061?lang=zh_cn&edition=full","pubTime":"2026-01-23 15:35","pubTimestamp":1769153717,"startTime":"0","endTime":"0","summary":"今日益丰药房涨10.02%，收盘报24.81元。2025年11月3日，中邮证券研究员盛丽华,龙永茂发布了对益丰药房的研报《业绩稳健增长，经营质量持续提升》，该研报对益丰药房给出“买入”评级。此外，东吴证券研究员朱国广,冉胜男,苏丰，东海证券研究员杜永宏,赖菲虹近期也对该股发布了研报，同样给出“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为国金证券的王麟。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300019724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603939","161027"],"gpt_icon":0},{"id":"2605133444","title":"异动快报：益丰药房（603939）1月23日9点31分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2605133444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605133444?lang=zh_cn&edition=full","pubTime":"2026-01-23 09:36","pubTimestamp":1769132209,"startTime":"0","endTime":"0","summary":"证券之星1月23日盘中消息，9点31分益丰药房触及涨停板。其所属行业医药商业目前上涨。领涨股为华人健康。该股为医药商业，互联网医疗，健康中国概念热股，当日医药商业概念上涨2.23%，互联网医疗概念上涨1.0%，健康中国概念上涨0.87%。1月22日的资金流向数据方面，主力资金净流入100.79万元，占总成交额0.64%，游资资金净流出560.53万元，占总成交额3.57%，散户资金净流入459.74万元，占总成交额2.93%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300008645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","LU2460026573.USD","LU2488822045.USD","LU2148510915.USD","LU1064131003.USD","603939","LU1064130708.USD"],"gpt_icon":0},{"id":"2602536659","title":"每周股票复盘：益丰药房（603939）可转债转股5,571股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602536659","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602536659?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:49","pubTimestamp":1768074547,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，益丰药房报收于22.21元，较上周的21.72元上涨2.26%。公司公告汇总：益丰药房为控股子公司石家庄新兴药房提供总额58,500.00万元的连带责任保证担保。公司公告汇总益丰药房关于可转债转股结果暨股份变动公告：截至2025年12月31日，累计有面值183,000元“益丰转债”转为公司A股普通股，累计转股5,571股，占转股前总股本的0.0005%。2025年第四季度期间，有面值2,000元“益丰转债”转股，转换为62股。公司总股本因可转债转股及股权激励事项有所变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","603939","LU2148510915.USD","LU1064131003.USD","BK0209","LU2460026573.USD","LU1064130708.USD"],"gpt_icon":0},{"id":"2601015158","title":"益丰药房（603939）披露为控股子公司提供担保的进展公告，1月7日股价上涨0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601015158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601015158?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:30","pubTimestamp":1767796234,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，益丰药房报收于22.18元，较前一交易日上涨0.27%，最新总市值为268.91亿元。近日，益丰大药房连锁股份有限公司发布关于为控股子公司提供担保的进展公告。公告显示，公司为控股子公司石家庄新兴药房连锁有限公司提供总额58,500.00万元的连带责任保证担保，涉及长沙银行、中国银行、民生银行和广发银行四家金融机构。被担保人石家庄新兴为公司持股91%的控股子公司，经营和财务状况稳定，担保风险可控。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700039035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2148510915.USD","LU2488822045.USD","LU2460026573.USD","LU1064130708.USD","LU1064131003.USD","603939","BK0209"],"gpt_icon":0},{"id":"2601000646","title":"益丰药房（603939）披露可转债转股结果暨股份变动公告，1月5日股价上涨0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601000646","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601000646?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:22","pubTimestamp":1767608544,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，益丰药房报收于21.87元，较前一交易日上涨0.69%，最新总市值为265.15亿元。公司近日发布公告称，截至2025年12月31日，累计有面值183,000元“益丰转债”转为公司A股普通股，累计转股5,571股，占转股前总股本的0.0005%。2025年第四季度期间，有面值2,000元“益丰转债”转股，转换为62股。尚未转股的可转债面值为1,797,249,000元，占发行总量的99.9898%。公司总股本因可转债转股及股权激励事项有所变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500028658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","603939","LU2488822045.USD","LU1064131003.USD","LU1064130708.USD","BK0209","LU2148510915.USD"],"gpt_icon":0},{"id":"2588000819","title":"益丰药房（603939）披露为控股子公司提供担保的进展公告，12月4日股价下跌0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588000819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588000819?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:32","pubTimestamp":1764840726,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘，益丰药房报收于23.34元，较前一交易日下跌0.89%，最新总市值为282.97亿元。公司近日发布公告称，益丰大药房连锁股份有限公司为全资子公司江苏益丰大药房连锁有限公司向中信银行股份有限公司南京分行申请20,000.00万元综合授信提供连带责任保证，担保期限自2025年10月28日至2026年10月27日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400027349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","603939","LU1064131003.USD","LU1064130708.USD","LU2148510915.USD","LU2488822045.USD","LU2460026573.USD"],"gpt_icon":0},{"id":"2585987704","title":"益丰药房（603939）披露2022年限制性股票激励计划部分限制性股票回购注销实施公告，11月24日股价下跌1.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585987704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585987704?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:42","pubTimestamp":1763995329,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，益丰药房报收于22.93元，较前一交易日下跌1.71%，最新总市值为278.01亿元。公司近日发布公告称，因5名激励对象离职、降级或绩效不达标，根据《上市公司股权激励管理办法》及公司2022年限制性股票激励计划相关规定，对其已获授但未解除限售的25,516股限制性股票进行回购注销。本次回购注销已于2025年11月27日完成，公司已履行相关决策程序和信息披露义务，并办理股份回购专用账户及过户手续。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400036444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","LU1064131003.USD","LU2460026573.USD","LU2488822045.USD","LU1064130708.USD","603939","LU2148510915.USD"],"gpt_icon":0},{"id":"2585106996","title":"每周股票复盘：益丰药房（603939）高管拟合计减持不超21.39万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585106996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585106996?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:45","pubTimestamp":1763844312,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，益丰药房报收于23.33元，较上周的24.88元下跌6.23%。本周，益丰药房11月17日盘中最高价报24.75元。本周关注点公司公告汇总：副总裁王永辉拟减持不超150,300股，副总裁肖再祥拟减持不超63,600股。二人因自身资金需求，拟通过集中竞价方式分别减持不超过150,300股和63,600股，合计不超过213,900股，减持比例均不超过各自持股的25%。减持期间为2025年12月8日至2026年3月7日，股份来源为股权激励及资本公积金转增股本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU2488822045.USD","LU2148510915.USD","LU1064131003.USD","603939","BK0209","LU2460026573.USD"],"gpt_icon":0},{"id":"2583666943","title":"益丰药房最新公告：高管王永辉、肖再祥合计拟减持不超0.0176%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2583666943","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583666943?lang=zh_cn&edition=full","pubTime":"2025-11-16 17:40","pubTimestamp":1763286013,"startTime":"0","endTime":"0","summary":"益丰药房(603939.SH)公告称，公司副总裁王永辉计划减持不超过15.03万股，占公司总股本比例不超过0.0124%；副总裁肖再祥计划减持不超过6.36万股，占公司总股本比例不超过0.0052%。减持方式为集中竞价交易，减持原因为自身资金需求，减持期间为2025年12月8日至2026年3月7日。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600008682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","601933","BK0077","LU1064131003.USD","BK0183","BK0170","BK0196","BK0209","LU1064130708.USD","LU2488822045.USD","603939","LU2148510915.USD"],"gpt_icon":0},{"id":"2579109635","title":"益丰药房（603939）2025年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579109635","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579109635?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:22","pubTimestamp":1761862957,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期益丰药房发布2025年三季报。截至本报告期末，公司营业总收入172.86亿元，同比上升0.39%，归母净利润12.25亿元，同比上升10.27%。按单季度数据看，第三季度营业总收入55.64亿元，同比上升1.97%，第三季度归母净利润3.45亿元，同比上升10.14%。本报告期益丰药房盈利能力上升，毛利率同比增幅0.03%，净利率同比增幅9.81%。持有益丰药房最多的基金为交银新成长混合，目前规模为48.9亿元，最新净值3.351，较上一交易日下跌1.06%，近一年上涨6.28%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100007969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603939"],"gpt_icon":0},{"id":"2579597978","title":"图解益丰药房三季报：第三季度单季净利润同比增长10.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579597978","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579597978?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:33","pubTimestamp":1761734000,"startTime":"0","endTime":"0","summary":"证券之星消息，益丰药房2025年三季报显示，前三季度公司主营收入172.86亿元，同比上升0.39%；归母净利润12.25亿元，同比上升10.27%；扣非净利润11.88亿元，同比上升8.8%；其中2025年第三季度，公司单季度主营收入55.64亿元，同比上升1.97%；单季度归母净利润3.45亿元，同比上升10.14%；单季度扣非净利润3.31亿元，同比上升8.08%；负债率54.42%，投资收益9976.95万元，财务费用1.13亿元，毛利率40.41%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900039319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603939"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774668596261,"stockEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":-0.0041},{"period":"3month","weight":0.0716},{"period":"6month","weight":-0.029},{"period":"1year","weight":-0.0276},{"period":"ytd","weight":0.1096}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0563},{"period":"3month","weight":-0.0126},{"period":"6month","weight":0.0224},{"period":"1year","weight":0.1601},{"period":"ytd","weight":-0.0139}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"益丰大药房连锁股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"20230人(较上一季度减少6.41%)","perCapita":"59930股","listingDate":"2015-02-17","address":"湖南省常德市武陵区白马湖街道富强社区人民路2638号","registeredCapital":"121239万元","survey":" 益丰大药房连锁股份有限公司的主营业务是中西成药、中药饮片、医疗器械、保健食品、保健用品、个人护理用品以及与健康相关联的日化便利、家居清洁等商品的全渠道零售业务。公司的主要产品是中西成药、中药、非药品。","listedPrice":19.47},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"益丰药房(603939)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供益丰药房(603939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"益丰药房,603939,益丰药房股票,益丰药房股票老虎,益丰药房股票老虎国际,益丰药房行情,益丰药房股票行情,益丰药房股价,益丰药房股市,益丰药房股票价格,益丰药房股票交易,益丰药房股票购买,益丰药房股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"益丰药房(603939)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供益丰药房(603939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}